Agneta Wennerholm
- Pharmacology top 0.5%
- Oncology top 10%
- Pharmacology top 10%
- Pediatrics, Perinatology and Child Health
- Endocrinology, Diabetes and Metabolism
- Co-authors
- Lars L. GustafssonLeif BertilssonMagnus Ingelman‐SundbergInger JohanssonJane SayiAmos MasseleMary JandeMarja‐Liisa Dahl
- Topics
- Pharmacogenetics and Drug Metabolism (12 papers)Drug Transport and Resistance Mechanisms (5 papers)Epilepsy research and treatment (4 papers)
- Cited by
- PharmacologyOncologyBiochemistry
In The Last Decade
Agneta Wennerholm
12 papers receiving 528 citations
Peers
Comparison fields: 5 of 57
- Pharmacology 478
- Oncology 234
- Pharmacology 113
- Pediatrics, Perinatology and Child Health 88
- Endocrinology, Diabetes and Metabolism 67
Countries citing papers authored by Agneta Wennerholm
This map shows the geographic impact of Agneta Wennerholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta Wennerholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta Wennerholm more than expected).
Fields of papers citing papers by Agneta Wennerholm
This network shows the impact of papers produced by Agneta Wennerholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta Wennerholm. The network helps show where Agneta Wennerholm may publish in the future.
Co-authorship network of co-authors of Agneta Wennerholm
This figure shows the co-authorship network connecting the top 25 collaborators of Agneta Wennerholm. A scholar is included among the top collaborators of Agneta Wennerholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agneta Wennerholm. Agneta Wennerholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 63 | |
| 2 | 22 | |
| 3 | 13 | |
| 4 | 15 | |
| 5 | 44 | |
| 6 | 69 | |
| 7 | 69 | |
| 8 | 51 | |
| 9 | 0 | |
| 10 | Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype. | 59 |
| 11 | 1 | |
| 12 | 68 | |
| 13 | 75 |
About Agneta Wennerholm
Agneta Wennerholm is a scholar working on Pharmacology, Clinical Biochemistry and Psychiatry and Mental health, having authored 13 papers that have together received 549 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (5 papers) and Epilepsy research and treatment (4 papers). The work is most often cited by research in Pharmacology (478 citations), Oncology (234 citations) and Biochemistry (53 citations). Agneta Wennerholm has collaborated with scholars based in Sweden, Tanzania and Spain. Frequent co-authors include Lars L. Gustafsson, Leif Bertilsson, Magnus Ingelman‐Sundberg, Inger Johansson, Jane Sayi, Amos Massele, Mary Jande, Marja‐Liisa Dahl, Yakoub Aden Abdi and Rajaa A. Mirghani. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Chromatography B and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.